TMCnet News

Research and Markets: Global Malignant Ascites Clinical Trials Report 2014
[April 15, 2014]

Research and Markets: Global Malignant Ascites Clinical Trials Report 2014


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/t5rcpd/malignant_ascites) has announced the addition of the "Malignant Ascites Global Clinical Trials Review, H1, 2014" report to their offering.

Malignant Ascites Global Clinical Trials Review, H1, 2014 provides data on the Malignant Ascites clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Ascites. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ofers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Ascites.



Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Clinical Trial Overview of Top Companies/Organisations


  • Neopharm Ltd.
  • Sanofi
  • MRC Biotech Pty Ltd
  • The Royal Marsden NHS Foundation Trust
  • Japan Interventional Radiology in Oncology Study Group
  • Masonic Cancer Center
  • AIO-Studien-gGmbH
  • Chiba University
  • Peking University
  • Huazhong University of Science & Technology
  • Nihon University
  • Baylor College of Medicine
  • North Central Cancer Treatment Group

For more information visit http://www.researchandmarkets.com/research/t5rcpd/malignant_ascites


[ Back To TMCnet.com's Homepage ]